[Form 4] Phibro Animal Health Corporation Insider Trading Activity
Jack Bendheim, who is listed as a director, 10% owner and President and CEO of Phibro Animal Health Corp (PAHC), reported a non鈥慸erivative acquisition on 08/15/2025 of 16,840 restricted stock units (RSUs). Each RSU represents a contingent right to one share of Class A common stock and was reported at a $0 price.
The filing shows 76,320 shares beneficially owned by the reporting person after the transaction. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to continued employment. The Form 4 was signed by an attorney鈥慽n鈥慺act on behalf of Mr. Bendheim on 08/19/2025.
Jack Bendheim, indicato come amministratore, azionista al 10% e Presidente e Amministratore Delegato di Phibro Animal Health Corp (PAHC), ha dichiarato un’acquisizione non derivata in data 15/08/2025 di 16.840 restricted stock units (RSU). Ogni RSU corrisponde al diritto condizionale su una azione di classe A e l’operazione 猫 stata riportata con prezzo di $0.
La comunicazione indica che, dopo la transazione, la persona segnalante detiene beneficiariamente 76.320 azioni. Le RSU maturano in quote sostanzialmente uguali in ciascuno dei primi tre anniversari del 1 agosto 2025, subordinatamente al mantenimento dell’impiego. Il Modulo 4 猫 stato firmato per procura da un legale in data 19/08/2025.
Jack Bendheim, registrado como director, propietario del 10% y Presidente y CEO de Phibro Animal Health Corp (PAHC), inform贸 una adquisici贸n no derivada el 15/08/2025 de 16.840 unidades restringidas de acciones (RSU). Cada RSU representa el derecho contingente a una acci贸n de clase A y se declar贸 a un precio de $0.
El informe muestra 76.320 acciones en propiedad beneficiaria de la persona informante tras la operaci贸n. Las RSU se consolidan en cuotas sustancialmente iguales en cada uno de los primeros tres aniversarios del 1 de agosto de 2025, sujeto a la continuidad del empleo. El Formulario 4 fue firmado por un apoderado en nombre del Sr. Bendheim el 19/08/2025.
鞛� 氩る摐頃橃瀯(Jack Bendheim)鞚� 鞚挫偓鞚挫瀽 10% 歆�攵� 氤挫湢鞛愳澊氅� Phibro Animal Health Corp (PAHC)鞚� 靷灔 瓴� CEO搿� 霌膘灛霅橃柎 鞛堨溂氅�, 2025-08-15鞐� 16,840臧滌潣 鞝滍暅攵� 欤检嫕 雼渼(RSU)毳� 牍勴寣靸� 氚╈嫕鞙茧 旆摑頄堧嫟瓿� 鞁犼碃頄堨姷雼堧嫟. 臧� RSU電� 韥措灅鞀� A 氤错喌欤检潣 1欤检棎 雽�頃� 臁瓣贝攵� 甓岆Μ毳� 雮橅儉雮措┌, 瓯半灅 臧�瓴╈潃 $0搿� 鞁犼碃霅橃棃鞀惦媹雼�.
鞁犼碃靹滌棎電� 瓯半灅 頉� 氤搓碃鞚胳澊 鞁れ鞝侅溂搿� 氤挫湢頃� 欤检嫕 靾橁皜 76,320欤茧 旮办灛霅橃柎 鞛堨姷雼堧嫟. RSU電� 2025雲� 8鞗� 1鞚�鞚� 觳� 氩堨Ц 旮半厫鞚检潉 鞁滌瀾鞙茧 頄ロ泟 3臧� 旮半厫鞚茧雼� 瓯办潣 霃欖澕頃� 牍勳湪搿� 氩犾姢韺呺悩氅�, 鞚措姅 瓿勳啀 瓿犾毄 靸來儨霛茧姅 臁瓣贝鞚� 鞛堨姷雼堧嫟. Form 4電� 2025-08-19鞐� 氩る摐頃橃瀯 鞌ゼ 雽�鞁犿暣 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
Jack Bendheim, inscrit en tant qu'administrateur, propri茅taire 脿 10% et Pr茅sident鈥慸irecteur g茅n茅ral de Phibro Animal Health Corp (PAHC), a d茅clar茅 une acquisition non d茅riv茅e le 15/08/2025 de 16 840 unit茅s d'actions restreintes (RSU). Chaque RSU repr茅sente le droit conditionnel sur une action de la classe A et a 茅t茅 d茅clar茅e au prix de 0 $.
Le d茅p么t indique que la personne d茅clarante d茅tient au total 76 320 actions apr猫s la transaction. Les RSU acqui猫rent des droits par tranches sensiblement 茅gales 脿 chacun des trois premiers anniversaires du 1er ao没t 2025, sous r茅serve de la poursuite de l'emploi. Le formulaire 4 a 茅t茅 sign茅 par un mandataire au nom de M. Bendheim le 19/08/2025.
Jack Bendheim, der als Director, 10%iger Eigent眉mer sowie President und CEO von Phibro Animal Health Corp (PAHC) gef眉hrt wird, meldete am 15.08.2025 den nicht-derivaten Erwerb von 16.840 Restricted Stock Units (RSUs). Jede RSU gew盲hrt das bedingte Recht auf eine Aktie der Klasse A; der Erwerb wurde mit einem Preis von $0 angegeben.
Die Meldung weist 76.320 wirtschaftlich gehaltene Aktien der meldenden Person nach der Transaktion aus. Die RSUs werden in ann盲hernd gleichen Raten an jedem der ersten drei Jahrestage des 1. August 2025 vesten, vorbehaltlich fortgesetzter Anstellung. Das Formular 4 wurde am 19.08.2025 von einem Bevollm盲chtigten im Namen von Herrn Bendheim unterschrieben.
- Equity alignment: The RSU grant increases the reporting person's stake to 76,320 shares, aligning executive and shareholder interests.
- Retention focus: Time鈥慴ased vesting over three years encourages continued executive service without immediate dilution from exercised options.
- None.
Insights
TL;DR: A routine executive equity grant that increases insider alignment without immediate cash cost or market sale.
The 16,840 RSU award is reported as a non鈥慶ash grant and increases the reporting person's beneficial ownership to 76,320 shares, which can signal management alignment with shareholders. Vesting over three years ties value realization to continued service rather than immediate liquidity, limiting near鈥憈erm dilution and market impact. There is no exercise price because these are RSUs, not options, and no sale or purchase of open鈥憁arket shares is recorded.
TL;DR: Standard executive compensation disclosure; vesting schedule conditions are time鈥慴ased and employment鈥慶ontingent.
The Form 4 documents a compensatory equity award subject to continued employment, a common corporate governance practice to retain senior executives. Reporting the award under Section 16 satisfies transparency requirements for insider holdings. The filing identifies the reporting person as director, 10% owner and President and CEO, clarifying potential related鈥憄arty considerations for governance review.
Jack Bendheim, indicato come amministratore, azionista al 10% e Presidente e Amministratore Delegato di Phibro Animal Health Corp (PAHC), ha dichiarato un’acquisizione non derivata in data 15/08/2025 di 16.840 restricted stock units (RSU). Ogni RSU corrisponde al diritto condizionale su una azione di classe A e l’operazione 猫 stata riportata con prezzo di $0.
La comunicazione indica che, dopo la transazione, la persona segnalante detiene beneficiariamente 76.320 azioni. Le RSU maturano in quote sostanzialmente uguali in ciascuno dei primi tre anniversari del 1 agosto 2025, subordinatamente al mantenimento dell’impiego. Il Modulo 4 猫 stato firmato per procura da un legale in data 19/08/2025.
Jack Bendheim, registrado como director, propietario del 10% y Presidente y CEO de Phibro Animal Health Corp (PAHC), inform贸 una adquisici贸n no derivada el 15/08/2025 de 16.840 unidades restringidas de acciones (RSU). Cada RSU representa el derecho contingente a una acci贸n de clase A y se declar贸 a un precio de $0.
El informe muestra 76.320 acciones en propiedad beneficiaria de la persona informante tras la operaci贸n. Las RSU se consolidan en cuotas sustancialmente iguales en cada uno de los primeros tres aniversarios del 1 de agosto de 2025, sujeto a la continuidad del empleo. El Formulario 4 fue firmado por un apoderado en nombre del Sr. Bendheim el 19/08/2025.
鞛� 氩る摐頃橃瀯(Jack Bendheim)鞚� 鞚挫偓鞚挫瀽 10% 歆�攵� 氤挫湢鞛愳澊氅� Phibro Animal Health Corp (PAHC)鞚� 靷灔 瓴� CEO搿� 霌膘灛霅橃柎 鞛堨溂氅�, 2025-08-15鞐� 16,840臧滌潣 鞝滍暅攵� 欤检嫕 雼渼(RSU)毳� 牍勴寣靸� 氚╈嫕鞙茧 旆摑頄堧嫟瓿� 鞁犼碃頄堨姷雼堧嫟. 臧� RSU電� 韥措灅鞀� A 氤错喌欤检潣 1欤检棎 雽�頃� 臁瓣贝攵� 甓岆Μ毳� 雮橅儉雮措┌, 瓯半灅 臧�瓴╈潃 $0搿� 鞁犼碃霅橃棃鞀惦媹雼�.
鞁犼碃靹滌棎電� 瓯半灅 頉� 氤搓碃鞚胳澊 鞁れ鞝侅溂搿� 氤挫湢頃� 欤检嫕 靾橁皜 76,320欤茧 旮办灛霅橃柎 鞛堨姷雼堧嫟. RSU電� 2025雲� 8鞗� 1鞚�鞚� 觳� 氩堨Ц 旮半厫鞚检潉 鞁滌瀾鞙茧 頄ロ泟 3臧� 旮半厫鞚茧雼� 瓯办潣 霃欖澕頃� 牍勳湪搿� 氩犾姢韺呺悩氅�, 鞚措姅 瓿勳啀 瓿犾毄 靸來儨霛茧姅 臁瓣贝鞚� 鞛堨姷雼堧嫟. Form 4電� 2025-08-19鞐� 氩る摐頃橃瀯 鞌ゼ 雽�鞁犿暣 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
Jack Bendheim, inscrit en tant qu'administrateur, propri茅taire 脿 10% et Pr茅sident鈥慸irecteur g茅n茅ral de Phibro Animal Health Corp (PAHC), a d茅clar茅 une acquisition non d茅riv茅e le 15/08/2025 de 16 840 unit茅s d'actions restreintes (RSU). Chaque RSU repr茅sente le droit conditionnel sur une action de la classe A et a 茅t茅 d茅clar茅e au prix de 0 $.
Le d茅p么t indique que la personne d茅clarante d茅tient au total 76 320 actions apr猫s la transaction. Les RSU acqui猫rent des droits par tranches sensiblement 茅gales 脿 chacun des trois premiers anniversaires du 1er ao没t 2025, sous r茅serve de la poursuite de l'emploi. Le formulaire 4 a 茅t茅 sign茅 par un mandataire au nom de M. Bendheim le 19/08/2025.
Jack Bendheim, der als Director, 10%iger Eigent眉mer sowie President und CEO von Phibro Animal Health Corp (PAHC) gef眉hrt wird, meldete am 15.08.2025 den nicht-derivaten Erwerb von 16.840 Restricted Stock Units (RSUs). Jede RSU gew盲hrt das bedingte Recht auf eine Aktie der Klasse A; der Erwerb wurde mit einem Preis von $0 angegeben.
Die Meldung weist 76.320 wirtschaftlich gehaltene Aktien der meldenden Person nach der Transaktion aus. Die RSUs werden in ann盲hernd gleichen Raten an jedem der ersten drei Jahrestage des 1. August 2025 vesten, vorbehaltlich fortgesetzter Anstellung. Das Formular 4 wurde am 19.08.2025 von einem Bevollm盲chtigten im Namen von Herrn Bendheim unterschrieben.
FAQ
What did Jack Bendheim report on Form 4 for PAHC?
How many shares does the reporting person own after this transaction?
What is the vesting schedule for the RSUs reported for PAHC?
Was there any cash paid for the RSUs in this Form 4?
Who signed the Form 4 on behalf of Jack Bendheim?
